Specific In Vivo Staining of Astrocytes in the Whole Brain after Intravenous Injection of Sulforhodamine Dyes by Appaix, Florence et al.
Specific In Vivo Staining of Astrocytes in the Whole Brain
after Intravenous Injection of Sulforhodamine Dyes
Florence Appaix
1,2*, Sabine Girod
1,2, Sylvie Boisseau
1,2, Johannes Ro ¨mer
1,2, Jean-Claude Vial
2,3,
Mireille Albrieux
1,2, Mathieu Maurin
1,2, Antoine Depaulis
1,2, Isabelle Guillemain
1,2, Boudewijn van der
Sanden
1,2
1Grenoble Institute of Neuroscience, Inserm U836, Grenoble, France, 2Universite ´ Joseph Fourier, Grenoble, France, 3Laboratoire Interdisciplinaire de Physique, CNRS
UMR 5588, Saint Martin d’He `res, France
Abstract
Fluorescent staining of astrocytes without damaging or interfering with normal brain functions is essential for intravital
microscopy studies. Current methods involved either transgenic mice or local intracerebral injection of sulforhodamine 101.
Transgenic rat models rarely exist, and in mice, a backcross with GFAP transgenic mice may be difficult. Local injections of
fluorescent dyes are invasive. Here, we propose a non-invasive, specific and ubiquitous method to stain astrocytes in vivo.
This method is based on iv injection of sulforhodamine dyes and is applicable on rats and mice from postnatal age to
adulthood. The astrocytes staining obtained after iv injection was maintained for nearly half a day and showed no adverse
reaction on astrocytic calcium signals or electroencephalographic recordings in vivo. The high contrast of the staining
facilitates the image processing and allows to quantify 3D morphological parameters of the astrocytes and to characterize
their network. Our method may become a reference for in vivo staining of the whole astrocytes population in animal models
of neurological disorders.
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Introduction
In vivo studies of astrocytes have gained importance over the last
ten years. These cells have been found to be implicated in
neurotransmission with the concept of the ‘tripartite synapse’ [1],
in neurovascular coupling [2,3,4] and in angiogenesis [5]. Possible
dysfunction of astrocytes has been suggested to be critical in
several neurological diseases [6,7,8].
Two-photon laser scanning microscopy (TPLSM) in vivo allows
imaging of biological tissue with micrometric spatial resolution and
gives access to numerous observations at the cellular level [9].
TPLSM has made possible in vivo studies of astrocytes in the intact
brain [10,11,12] and has opened a new field of dynamic and
functional studies on neuron-astrocytes and astrocytes-vasculature
interactions [13]. To this aim, transgenic mice expressing
fluorescent protein under astrocyte specific promoter (human glial
fibrillary acidic protein, S100…) have been developed [14].
However, crossing mice carrying two transgenes, using e.g. the cre
lox system [15], with GFAP transgenic mice is not trivial. Further,
rats are often used to study normal brain functions or
neuropathologies, but transgenic rat models are difficult to
generate [16,17]. Thus, alternative methods to stain astrocytes in
vivo are necessary. In 2004, a method was proposed for in vivo
astrocytes staining in the neocortex of anesthetized rats and mice
using sulforhodamine 101 (SR101) [12]. The dye was directly
applied on the brain cortex for local astrocytes staining via the gap
junctions or intracerebrally injected for deeper labeling. However,
this technique requires invasive introduction of a patch pipette in
the brain tissue which may interfere with physiological functions.
Recently, we found that sulforhodamine B (SRB) injected
intravenously (iv) specifically stained astrocytes in mice neocortex
[18]. SRB is a non-toxic molecule with an oral LD50=10300 mg/
kg of body weight [19,20]. Moreover, sulforhodamine dyes family
and in particular SR101, SRB and SRG show a high two-photon
absorption cross section (sTPE,150 GM) [21] with an emission
and a two-photon absorption wavelength located in the spectral
region of interest for deep bio-imaging: 680–1040 nm. The
possibility to use these fluorescent dyes in a non-invasive way
makes them a powerful tool for in vivo studies of astrocytes.
The aim of the present study was to characterize the astrocytes
staining obtained after iv injection of sulforhodamine dyes (SR101,
SRB or SRG). We performed TPLSM on mice and rats from
newborn stages to adulthood in acute brain slices and in vivo.W e
verified the compatibility of this method with astrocytes calcium
imaging and electroencephalography (EEG) recordings in freely
moving rats. Finally, a three dimensional (3D) analysis of the
astrocytic network has been done to quantify astrocytes distribu-
tion and density in the neocortex. The use of this 3D image
processing was further demonstrated in the hippocampus of a
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morphological changes of astrocytes reported earlier [22,23].
Materials and Methods
1 Ethics Statement
In accordance with the policy of Grenoble Institute of
Neuroscience (GIN) and the French legislation, experiments were
done in compliance with the European Community Council
Directive of November 24, 1986 (86/609/EEC). The research
involving animals was authorized by the Direction De ´partemen-
tale des Services Ve ´te ´rinaires de l’Ise `re – Ministe `re de l’Agricul-
ture et de la Pe ˆche, France and the Direction De ´partementale de
la protection des populations - Pre ´fecture de l’Ise `re-France (F.
Appaix, PhD, permit number 38 09 39). All efforts were made to
minimize the number of animals used and their suffering during
the experimental procedure.
Animals were housed in cages with food and water ad libitum in a
12 h light/dark cycle at 2261uC.
2 Chemicals
All chemicals were purchased from Sigma-Aldrich (France).
SR101, SRB or SRG were dissolved in 0.9% NaCl (saline) at the
concentration of 10 mg/ml. Fluorescein IsoThioCyanate-dextran
(FITC-dextran, 70 kDa) was diluted at 100 mg/ml concentration
in saline. Dyes solutions were stored at 4uC and protected from
light for a maximum of one month.
3 Animals and surgical preparation
Rats (Sprague Dawley, postnatal day (P) 17–70, n=32, Wistar,
P17–30, n=21, Janvier, France) and mice (adult male C57BL/6,
P42–70, n=5, Janvier, France; and FVB/N-
Tg(GFAPGFP)14Mes/J, P20–45, n=4, Jackson Laboratory, US)
were used.
For in vivo TPLSM imaging, animals were anesthetized using
isoflurane (5% for induction and 1–2% during experiments) in a
70% air, 30% O2 gas mixture. Their body temperature was
monitored with a rectal probe and maintained at 36uC using a
heating blanket. A catheter (Neoflon
TM, BD, USA) was inserted in
the tail vein and SRB, SRG or SR101 (20 mg/kg), and/or FITC-
dextran (200 mg/kg) was iv injected. A craniotomy of 2–3 mm in
diameter was performed with a surgical drill above the
somatosensory and motor cortex and filled with chilled artificial
cerebrospinal fluid (aCSF; in mM: 126 NaCl, 2.5 KCl, 2.5 CaCl2,
1.2 MgCl2, 1.20 NaH2PO4, 25 NaHCO3, 1 sodium pyruvate and
22 D-glucose; bubbled with 95% O2 and 5% CO2; pH 7.4). In
some case, the dura mater was carefully removed and the exposed
cortex was protected by aCSF and covered with a coverslip glued
on the skull. To compare our iv method with a previous report
[12], 50 ml of SR101 was directly applied (5 min, 100 mMi n
aCSF) on the cortical surface.
For experiments on acute brain slices, animals were iv injected
with SRB, SRG or SR101 as described above. One hour after
injection, rats were anesthetized by ketamine injection (Imalge `neH,
Ke ´tamine Virbac, France; 100 mg/kg), decapitated, and their
brain was quickly removed. Coronal brain slices with a thickness of
300 mm were cut (vibratome V1000S, Leica, Germany) in ice-cold
low Ca
2+- high Mg
2+ artificial cerebrospinal fluid (aCSF; in mM:
126 NaCl, 2.5 KCl, 0.5 CaCl2, 7 MgCl2, 1.20 NaH2PO4,2 5
NaHCO3, 1 sodium pyruvate and 22 D-glucose; bubbled with
95% O2 and 5% CO2; pH 7.4). Following sectioning, all slices
were kept at room temperature in normal aCSF (in mM: 1.20
MgCl2 and 2 CaCl2) until TPLSM imaging for a maximum of
6 hours. For comparison with the iv injection, acute brain slices
from non-injected animal were incubated with SR101 (15 min,
final concentration 1 mM) [24].
For the epilepsy mouse model, 6 week-old animals were injected
in the dorsal intrahippocampus with 1 nmol of kainic acid (50 nl),
2 weeks before iv SRB injection, as previously described [22,23].
The cannula was positioned in the right dorsal hippocampus
(coordinates from bregma: anteroposterior [AP]=2.0 mm, me-
diolateral [ML]=1.5 mm, dorsoventral [DV]=2.0 mm) and the
kainic acid solution was injected during one minute using a micro-
pump (CMA/100, Carnegie Medicine). Only animals showing
signs of focal status epilepticus (e.g., mild clonies, rotations) during
the 12 h following kainic acid injection were included in the study.
4 Two-photon microscopy and two-photon fluorescence
spectra
Two-photon microscopy was performed using a LSM 7 MP
(Zeiss, Germany) equipped with a 206water-immersion objective
(NA 1.0; Zeiss) and ZEN 2009 software. Laser excitation at 800–
900 nm was done with a Ti:Sapphire laser system (Chameleon
vision II; Coherent, UK). Fluorescence light was collected in the
epifluorescence configuration. The sulforhodamines fluorescence
was separated from the FITC or GFP fluorescence using a
dichroic mirror (562 nm, Semrock, US). Fluorescence emissions
were detected simultaneously by two non-descanned photomulti-
plier tubes with a 542/50 nm filter (Semrock, US) for ‘‘green’’
fluorescence emission and a 617/73 nm filter (Semrock, US) for
‘‘red’’ fluorescence emission.
Fluorescence emission spectra were measured using 100 mM
solutions of SRB or SR101 dissolved in water. Fluorescence
intensities of these solutions were recorded on the microscope as a
function of excitation wavelengths ranging from 720 nm to
950 nm in steps of 10 nm using a constant laser power (50 mW
on the sample).
5 Immunolabeling
Immunostaining on living brain slices was performed to
characterize SRB-positive cells. Slices from SRB-injected rat brain
were incubated for one hour at room temperature with either anti-
NG2 antibody diluted in aCSF (1:1000, DAKO) or anti-NeuN
antibody (1:1000, DAKO) diluted in aCSF with 0.005% Pluronic
acid F-127 (Molecular Probes, Invitrogen), 0.00025% Cremophor
EL (Sigma-Aldrich) and 0.05% DMSO (dimethyl sulfoxide,
Sigma-Aldrich) saturated with 95% O2/5% CO2. Slices were
rinsed twice in aCSF and incubated with an anti-mouse Alexa488-
conjugated secondary antibody (1:1000; Molecular Probes,
Invitrogen) for one hour at room temperature. Finally, slices were
put in aCSF for TPLSM imaging.
Above immunostaining method described for living brain slice
could not be used for anti-S100B and anti-CD11 antibodies. Thus,
a method was developed to merge astrocytes sulforhodamine
staining acquired in living slice with immunostaining performed
on the same slice after fixation. Rats were intravenously injected
with both SRB and FITC-dextran. Blood vessels stained with
fixable FITC-dextran were used as landmarks to merge images
from the living and the fixed slice. Slices were then fixed with 4%
paraformaldehyde in Tris Buffer Saline (TBS) with 0.3% triton-
X100 (TBST) for 1 hour and incubated with 3% normal goat
serum (NGS) in TBST at room temperature for 30 min. The
incubation with the antibodies anti-S100B (1:1000, DAKO) and
anti-CD11 (1:100, AbCys) in 1% NGS-TBST was performed
overnight at 4uC. Then, after rinsing, slices were incubated with
fluorescent secondary antibodies diluted in 1% NGS-TBST for
2 hours at room temperature: anti-rabbit Alexa488-conjugated
secondary antibody (1:1000; Molecular Probes, Invitrogen) for
In Vivo Staining of Astrocytes
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35169anti-S100B or anti-mouse Alexa488-conjugated (1:1000; Molecu-
lar Probes, Invitrogen) for anti-CD11. Finally, slices were rinsed in
TBST and mounted on slides using Vectashield medium (Vector
labs, USA). Shrinkage caused by fixation was corrected using the
‘‘TurboReg’’ plugin [25] of ImageJ software to merge sulforho-
damine staining with immunolabeling.
6 Electroencephalographic (EEG) recordings in freely
moving rat
Sprague-Dawley rats (P25; n=4 for SRB and n=4 for SR101)
were anesthetized with 1% isoflurane in a 70% air, 30% O2 gas
mixture and placed in a stereotaxic apparatus. Bipolar electrodes
(stainless steel wire 220 mm, insulated with Teflon) with a mean
space of 300 mm between the 2 tips were unilaterally implanted
into the S1BF somatosensory cortex (coordinates relative to
bregma: anteroposterior (AP): 21.3, mediolateral (ML): 25,
dorsoventral (DV): 23), into the M1 motor cortex (coordinates
relative to bregma: AP: +1.6, ML: 22.5, DV: 22) and into the
hippocampus (coordinates relative to bregma: AP: 23.7, ML:
22.5, DV: 23.5). These electrodes were fixed to the skull with
acrylic cement and connected to a female connector. Reference
electrode was made of a stainless-steel screw fixed over the
cerebellum and soldered to the connector. On the following day,
the behavior and EEG activity was monitored in freely moving rat
pups using a video/EEG computer-based acquisition system
(System Plus EvolutionH, Micromed, France). The rats were first
monitored for 1 h for reference. Then, either SRB or SR101
(20 mg/kg) was intravenously injected as described above and
then both EEG activity and behavior were monitored during 3
days for sessions of 3 consecutive hours.
7 Calcium Imaging
A solution containing 5 mM Fluo-4 AM (Molecular Probes,
Invitrogen, US), 0.005% Pluronic acid F-127 (Sigma-Aldrich,
France), 0.00025% Cremophor EL (Sigma-Aldrich, France) and
0.05% DMSO (Sigma-Aldrich, France) was prepared in aCSF.
Brain slices obtained as described above were loaded with this
solution during 30 minutes at 35uC. The loading chamber was
continuously bubbled with 95% O2/5% CO2. Slices were then
placed in aCSF saturated with 95% O2/5% CO2 and supple-
mented with 1 mM sodium pyruvate, at room temperature for
30 minutes. Before imaging, slices were placed in a perfusion
chamber and perfused with aCSF bubbled with 95% O2/5% CO2
at room temperature. Confocal imaging was done with an upright
microscope (Eclipse E600 FN, Nikon Instruments, France)
equipped with a 206water-immersion objective (NA 0.5; Nikon)
and a confocal head (confocal C1 head, Nikon). Fluo-4 was excited
with an argon laser (488 nm) and emission was filtered with a
515615 nm filter, SRB or SR101 were excited with a HeNe green
laser (543 nm) and emission was filtered with a 605675 nm filter.
Images were acquired with EZ-C1 software (Nikon), in 12-bit
encoded format. 5126256 images were taken at 800 ms intervals.
For in vivo experiments, after removing the dura mater, 10 mlo fa
solution containing 0.9 mM Fluo-4 AM (Molecular Probes,
Invitrogen, US), 2% Pluronic acid F-127 (Sigma-Aldrich, France)
and 20% DMSO (Sigma-Aldrich, France) prepared in aCSF/
Hepes were applied at the cortical surface for 45 min and rinsed
with aCSF for 10 min. Time lapse recordings obtained were
analyzed with CalSignal software [26].
8 Image Processing and Statistical Analysis
Image processing was performed with ImageJ software [27].
Multistacks mosaic was reconstructed using the ‘‘3D stitching’’
plugin [28]. Quantitative analysis of the astrocytic network was
based on a 3-step procedure. First, raw images were segmented by
adaptive thresholding (Bernsen) to facilitate automated cell
detection. The result was then analyzed using the ‘‘Particle
Analyzer’’ included in the BoneJ plugin [29] to determine the
spatial coordinates of all detected objects. Finally, V3D software
[30] was employed to visualize the raw images in 3D and to
superpose markers for the detected cells in order to manually
correct the result. Thus, non-detected cells can be added and
artefactual objects can be removed. Normalized radial densities
were calculated by dividing the histogram of the distances r
between all labeled cells (bin width 3 mm) by N4pr
2, where N is the
total number of cells in the z-stacks [12]. The volume of astrocyte
cell bodies was estimated using the ‘‘3D object counter’’ plugin
[31] in ImageJ. Origin software (OriginLab) was used for statistical
analyses of the epilepsy mouse model. Data are reported as mean
6 s.e.m. Significant differences (p,0.05) between data obtained
from the left (non-injected) and the right (injected) hippocampi
were calculated using a Student’s t-test.
Results
1 Systemic iv injection of sulforhodamine specifically
stain astrocytes in the entire brain
In a first set of experiments, we analyzed whether the systemic iv
injection of SRB, SRG or SR101 specifically stained astrocytes in
the whole brain of mice and rats at different times post-injection
using in vivo TPLSM. This staining was then compared to the one
obtained after local application of SR101 on the cortical surface
[12].
Rats (18–28 days old) (n=6) were anesthetized and injected
with SRB (20 mg/kg) in the tail vein followed by a craniotomy and
positioned on the motorized platform (Siskiyou, US) of the two-
photon microscope. During the first 10 min, SRB was only
detected in the vascular compartment (Fig. 1A). At 40 min post-
injection, SRB was still found in the vasculature and accumulation
occurred in numerous cells (Fig. 1A) with a shape consistent with
astrocytes morphology, i.e.: cell body diameters varying between 8
and 10 mm and endfeet linked to blood vessels. 90 min after the iv
injection, no SRB remained in blood vessels, whereas astrocytes
cell bodies were still labeled (Fig. 1A). This pattern of staining
persisted up to 5 hours after 100 ml injection of SRB (20 mg/kg).
Figure 1B shows an example of fluorescence intensity changes as a
function of time in both astrocytes and blood vessels. As shown in
Fig. 1C, at 250 mm of depth, corresponding to the somatosensory
cortex layer 2/3, SRB-stained astrocytes were observed with their
endfeet linked to blood vessels (white arrowhead). Intermingled
non-stained regions of larger diameter (20 mm; white arrows) were
reminiscent of neurons soma suggesting that SR101 did not stain
these cells after iv injection. The dose of the injected dye was
chosen to obtain the best contrast and the longest staining
duration. The dose of 20 mg/kg used in our experiment
corresponds to the maximum amount of dye that can be injected.
This quantity was limited by the sulforhodamine solubility in water
and the volume that can be intravenously injected as a bolus in
rats. Nevertheless, it is possible to decrease the dose but the
staining may be less contrasted and may be cleared more rapidly.
Similar staining was observed following iv injection of the same
dose of SR101 or SRG (n=5; data not shown).
To compare the astrocytes labeling obtained using SRB or
SR101, we injected intravenously both dyes in a 1:1 mixture. The
intracerebral capture of dyes was observed with TPLSM in acute
brain slices using different excitation wavelengths. The maximum
two-photon excitation wavelength is different for these two
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920 nm for SR101 respectively (Fig. 2A). At 900 nm, with low
laser power (less than 50 mW), emission of SRB is negligible and is
close to the maximum for SR101 and vice versa at 800 nm.
Therefore, two separate images could be obtained. The merge
(pink in Fig. 2A) of SRB (red; 800 nm) and SR101 (blue; 900 nm)
images provides evidence that these two dyes stain the same cell
population. In order to confirm that the stained cells were also
GFAP
+, SRB was iv injected in transgenic mice (n=4 animals,
n=1529 cells) expressing the green fluorescent protein (GFP)
under the control of the hGFAP promoter [14]. We observed that
the vast majority of GFP positive cells (8962%) were also stained
by SRB (Fig. 2B). It is important to note that the population of
SRB-stained cells (red) exceeded the population of GFP-stained
cells in a cortical brain slice. Indeed, we noticed that 5862% of
SRB labeled cells were not GFP positive. To characterize this
Figure 1. Astrocytes are progressively stained in vivo after an intravenous injection of sulforhodamine B. A) 10 min after an iv injection
of SRB (P18 rat) only blood vessels were observed, 40 min after the injection both vessels and astrocytes were stained and 90 min after the injection
only astrocytes could be imaged. Scale bar=50 mm. B) Curve of the fluorescence intensity changes in both astrocyte and blood compartments as a
function of time. C) In vivo two-photon imaging of cortical astrocytes at a 250 mm depth (P21 rat) 30 minutes after SRB (20 mg/kg) iv injection.
Arrows show non-stained regions corresponding to neuron soma and the arrowhead corresponds to an astrocytic end-foot linked to a blood vessel.
Scale bar=50 mm.
doi:10.1371/journal.pone.0035169.g001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35169Figure 2. Sulforhodamine stained cells are only astrocytes. A) Two-photon excitation spectra of SRB and SR101 shows the possibility to excite
one dye without exciting the other. Z-projection (standard-deviation) of a 100 mm stack acquired on an acute coronal brain slice of rat somatosensory
cortex (P23) after iv injection of SRB/SR101 mix (1:1) and FITC-dextran to stain vasculature. The left merged image was acquired with an 800 nm laser
excitation wavelength, corresponding to SRB (orange) and FITC-dextran (green) emissions. The central merged image was acquired with a 900 nm laser
excitation wavelength, corresponding to SR101 (red) andFITC-dextran(green) emissions. Theright panelshows a mergeof SRB, SR101andFITC-dextran
(pinkcorrespondstoSRBandSR101colocalization).Scalebar=50 mm.B)Z-projection(standard-deviation)oftwo-photonmicroscopyimagesofcortical
brain slices from GFAP-GFP transgenic mouse (P37) 2 h after iv injection of SRB. Left image shows SRB staining (red), central image shows GFAP-GFP
expression (green) and right panel is a merge of left and central images with double-stained cells appearing in yellow. C) Z-projection (standard-
deviation) of TPLSM images of cortical brain slices from a P18 rat. Left image: SRB astrocytes staining after iv injection (red), central image: slice
immunostained with S100B antibody (green). Right panel is a merge of left and central images with double-stained cells appearing in yellow. D) Merge
images of SRB-stained slices (red) secondarily immunostained with NG2 antibody (green, left panel), or NeuN antibody (green, central panel), or CD11b
antibody (green, right panel). Arrowheads show NG2 cells or microglial cells which are not SRB-stained. Scale bar=20 mm.
doi:10.1371/journal.pone.0035169.g002
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iv injected rats. Several antibodies were used, one directed against
S100B (S100 calcium binding protein B), that has been shown to
be specifically expressed in astrocyte cell body [32], another
directed against NG2 (chondroitin sulfate proteoglycan) cells, cells
able to generate oligodendrocytes and a subset of protoplasmic
astrocytes [33], another directed against a neuron-specific nuclear
protein (NeuN) and a later one directed against an integrin
expressed on the microglial cells surface (CD11b) [34]. As shown
in Fig. 2C, all SRB-stained cells also expressed S100B confirming
that sulforhodamine stained astrocytes (n=10 slices from 4 rats).
On the contrary, NG2, NeuN and CD11b staining showed no
overlap with SRB indicating that sulforhodamine stained cells
were not NG2 cells, neurons or microglial cells (Fig. 2D).
We further combined the SRB astrocytes labeling with a
staining of the vascular network by an additional iv injection of
FITC-dextran in vivo or 1 hour before euthanizing the rats for
brain slice experiments. The labeling of the vasculature was
conserved in acute brain slices (Fig. 3A) and permitted to analyze
the vascular network also in subcortical areas. Depending on the
vessels types, almost their entire surface was covered either by
astrocyte endfeet (1) or astrocytic cell bodies (2) or pericytes (3)
(Fig. 3B).
We hypothesized from the previous results that iv injection of
SRB, SRG or SR101 stained astrocytes in the entire brain. To
prove this, we prepared acute living brain slices at least 2 h after
SR101 iv injection (20 mg/kg, n=6 animals), to ensure clearance
of the dye from the blood plasma. Note that in vivo TPLSM is
limited to the maximum depth of approximately 800 mm.
However, on brain slices, astrocytes could not only be detected
in the neocortex (Fig. 4A), but also in the hilus of the dentate gyrus
(Fig. 4B), in the substantia nigra pars reticulata (Fig. 4C) and in the
cerebellum as Bergmann glia cells of cerebellar cortex (Fig. 4D).
Larger images of a part of the cerebellum (Fig. S2 A), the whole
hippocampus (Fig. S2 B) or all cortical layers of the S1BF (Fig. S3)
show the different labeling pattern. On the contrary, when brain
slices of non-injected rats (n=4) were incubated with SR101
(15 min; final concentration 1 mM), stained astrocytes were only
detected in the cortex and the hippocampus. In addition, neurons
were not stained deeper than 80 mm (Fig. 4E–F).
Then we compared our staining method (Fig. 5A1–3) with a
cortical application of SR101 (Fig. 5B1–3, n=3). TPLSM imaging
at the surface of the cortex revealed a reduced astrocytes staining
with a lower contrast in comparison to images obtained following
sulforhodamine iv injection (compare Fig. 5A1 and B1). Moreover,
the iv injection method showed a maximum imaging depth of
500 mm under the cortical surface in comparison to a maximum
imaging depth of around 200 mm using the incubation method
(compare Fig. 5A3 and B3).
2 Lack of adverse reactions following sulforhodamine iv
injection
In the second part of this study, we verified whether the staining
of the astrocytic population was compatible with physiological
experiments. This staining could be helpful to discriminate
astrocytes from neurons after loading with calcium indicators that
accumulate in both cell types.
First, we have to verify that the sulforhodamine astrocyte
staining did not interfere with astrocyte calcium oscillations in
acute brain slices or in vivo. In acute brain slices, calcium
oscillations in astrocytes were monitored using Fluo-4 AM, in
the hippocampus, in the cortical layers 2/3 as well as in the
substantia nigra pars reticulata for 150–200 seconds at 1 Hz.
During a 5-min recording, more than 20% of the astrocytes
recorded in the cortex showed spontaneous calcium signals with
no apparent synchrony (n=9 slices from 3 animals; 270 cells)
(Fig. 6A). Spatiotemporal patterns of astrocytes spontaneous
calcium signals recorded were consistent with signals obtained in
other studies [35]. Moreover, application of ATP (5 mM), an
agonist of P2Y receptors widely expressed on astrocytes [36,37],
induced a intracellular calcium rise in more than 40% of the SRB
stained astrocytes (n=6 slices) (Fig. 6B) similar to signals recorded
without SR101 (n=5 slices) (Fig. 6C).
Spontaneous calcium activity in vivo was recorded for 10 min-
utes using Fluo-4 AM in astrocytes of somatosensory cortex layer
2/3 at approximately 200 mm deep after SR101 astrocytes staining
(Fig. 6D). We observed in our recordings that the duration and the
amplitude of calcium activities were not modified by the
sulforhodamine (n=3).
Secondly, a recent study reported epileptiform activities in
hippocampal slices and in vivo after local application of SR101 (2–
5 ml, 10 mM) [38]. Others studies using intracerebral injections of
smaller volumes of SR101 never reported such adverse effect
[12,35]. Therefore, we examined whether epileptic activities
occurred after iv injection of SRB or SR101. Cortical and
hippocampal EEG was recorded in freely moving rats (P25) for 3 h
sessions during 3 days after iv injection of SRB (20 mg/kg; n=4
rats) or SR101 (20 mg/kg; n=4 rats). Visual analysis of the video/
EEG recordings, using bipolar derivations, did not reveal any
spikes, polyspikes or epileptiform discharges and no abnormal
behavior reminiscent of tonic or clonic seizures (Fig. S1).
3 Morphological analysis of the sulforhodamine-stained
astrocytic network
The ubiquitous and homogeneous astrocytes staining in the
entire brain and the high contrast of images obtained following iv
injection of SRB, SRG or SR101 enabled 3D morphological
analysis of the astrocytic network. Similar analysis of GFAP-GFP
mice was less accessible due to a heterogeneous GFAP expression
in astrocytes. Images from the cortex of 5 rats (P17–19) were
quantitatively analyzed to determine morphological parameters,
such as (i) astrocyte volume density as a function of depth, (ii) cell
body volumes and (iii) distances between neighboring cell bodies
(normalized radial density).
Using ImageJ plugins for image processing, astrocyte cell bodies
were first identified to determine their 3D coordinates. This
enabled to calculate the number of astrocytes in a given volume as
well as the normalized radial densities. A multistacks mosaic of the
Figure 3. Astrocytes and blood vessels staining in acute
cortical brain slices (P23 rat). A) Astrocytes are SRB labeled (red)
whereas the vessels are stained by FITC-dextran (green). Scale
bar=50 mm. B) Higher magnification of image A showing that most
of the surface of the vessels was covered by either astrocytic endfeet (1)
or astrocytic cell bodies (2) or pericytes (3). Scale bar=20 mm.
doi:10.1371/journal.pone.0035169.g003
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brain slice. A region of interest containing all the cortical layers has
been selected for the analysis (Fig. 7A). The astrocyte volume
density (n=150–200 cells from 5 animals, P17–19) was 19.2
10
360.4 10
3 cells/mm
3 in the cortical layer 1 (L1), and 13.7
10
360.9 10
3 cells/mm
3 in the layers 2/3 (L2/3) (Fig. 7B). The
normalized radial density histograms showed a mean cell-to-cell
distance between 20 and 30 mm in the L1 (Fig. 7C). This was
consistent with the uniform arrangement observed in images
obtained from this area (Fig. 7D). By contrast, in the L2/3,
histograms suggested the existence of two cell populations (Fig. 7E):
(i) one with a normalized radial density around 10 mm and (ii) a
population with a normalized radial density between 35 and
40 mm. Cells with the smallest normalized radial density appeared
mostly as pairs (Fig. 7F) as previously described [12]. Further, a
Figure 4. Comparison of two methods for astrocytes staining in acute brain slices (thickness of 300 mm, P18 rat). TPLSM images: A–D)
brain slicing performed 2 h after intravenous injection of SR101 (20 mg/kg) and E–F) brain slices incubated 15 minutes with SR101 (final
concentration 1 mM) in aCSF. Z-projections (standard-deviations) of acquired stacks: A) in the cortical L1 and L2/3 (stack thickness 300 mm); B) in the
dentate gyrus (stack thickness 150 mm); C) in the substantia nigra pars reticulata (stack thickness 100 mm) and D) in the cerebellum (stack thickness
50 mm). Images collected after incubation with SR101: E) at the surface of the slice, and F)8 0mm deeper from the brain slice surface. Scale
bar=50 mm.
doi:10.1371/journal.pone.0035169.g004
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3 was found in the rat
neocortex (P17).
This 3D analysis can be performed on neurological disorder
models to study morphological modifications of astrocytes. We
applied our method to a mouse model of mesiotemporal lobe
epilepsy obtained by intrahippocampal injection of kainic acid
(n=5 mice). This model is characterized by a unilateral loss of
pyramidal neurons in the CA1, CA3 and hilus regions, along with
a dispersion of granule cells of the dentate gyrus and a massive
hypertrophy of astrocytes with an extension of long radially-
oriented processes in the ipsilateral dentate gyrus [22,23]. Two
weeks after kainic acid injection, a loss of pyramidal cells in the
CA1, CA3 and hilus was observed in the ipsilateral hippocampus
of all injected mice, as compared to the contralateral side (Fig. 8A–
B). A drastic reorganization of the astrocytic network was observed
in the ipsilateral side (Fig. 8C–D), as previously described [22].
The 3D analysis confirmed that the mean volume of the astrocytes
cell body was significantly increased (12126111 mm
3; n=194
cells; p,0.05) at the injected side in comparison to the
contralateral side (804633 mm
3; n=228 cells) (Fig. 8E). The
Figure 5. Comparison of two in vivo methods for astrocytes staining (P21 rat). TPLSM images acquired: A1–3) 30 minutes after SRB (20 mg/
kg) intravenous injection and B1–3) 5 minutes after SR101 application (100 mM) on the cortical surface. (A1) and (B1) Images were taken at 100 mm
below the pia.mater (A2) and (B2) Images were taken at 250 mm below the surface of the cortex. (A3) and (B3) show a 3D reconstruction (V3D) using
the entire stack of images. Scale bar=50 mm.
doi:10.1371/journal.pone.0035169.g005
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35169Figure 6. Calcium signaling in neocortical astrocytes stained with SR101. A) Left panel: merged confocal images of astrocytes labeled with
SR101 (iv injection; red) and incubated with 5 mM Fluo-4 AM (green) in acute brain slice (P17 rat). Right panel: example of typical fluorescence
variations measured in three SR101-stained astrocytes within the somatosensory cortex. B) Left panel: merged confocal imaging of astrocytes stained
with both SR101 (red) and Fluo-4 AM (green). Right panel: example of fluorescence increase induced by ATP (5 mM) measured in three typical SR101
positive cells. C) Left panel: confocal imaging of astrocytes loaded with Fluo-4 AM (green). Right panel: example of fluorescence increase induced by
ATP (5 mM) measured in three loaded astrocytes. D) Left panel: TPLSM imaging of cortical astrocytes in vivo 1 hour after an iv injection of SR101 (P18
rat, depth=200 mm). Right panel: example of fluorescence variations measured in two SR101-stained astrocytes within the somatosensory cortex
layer 2/3 labeled with Fluo-4 AM. Scale bar=50 mm.
doi:10.1371/journal.pone.0035169.g006
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PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e35169wider distribution and the increased mean of astrocytes cell body
volumes in the injected hippocampus could be attributed to a
population of astrocytes that presented elongated cell bodies, see
Fig. 8D and previous report [22].
Discussion
In the present study, we propose a noninvasive method to
specifically stain astrocytes in the whole rat or mouse brain in vivo
using an intravenous injection of sulforhodamine dyes.
As observed in this study, SRB, SRG or SR101 were able to
cross the blood brain barrier (BBB) after iv injection and stained
cells in the brain of rat pups as well as adults and mice.
Morphological characteristics of these labeled cells and immuno-
labeling experiments strongly suggest that sulforhodamines
specifically stained astrocytes. The choice of the sulforhodamine
dye (SR101 (Em 606 nm), SRB (Em 588 nm) and SRG (Em
533 nm)) can be adapted to avoid spectral overlap with others
dyes.
These SRB, SRG or SR101-astrocytes were probably stained
via their endfeet close to the basal lamina of the blood vessels. The
mechanism of dye trafficking from the vasculature into astrocytes
remains unknown. However, considering the physicochemical
properties of the sulforhodamines (i.e. a small and highly polar
molecule), we hypothesize that sulforhodamine dye may diffuse
passively across the blood vessel endothelium and accumulate in
the perivascular space, between the astrocytic endfeet membrane
and the basal lamina. Then, connexins, and especially Cx43,
might enable specific uptake of sulforhodamine by astrocytes
because of their localization in the endfeet membrane [13,39].
Moreover, Cx43 is a well known hemi-channel involved in
intercellular communication within the astrocytic network.
Therefore the dyes might circulate over the astrocytic network
via these connexins. This hypothesis is in good agreement with a
previous study where carbenoxolone (a gap-junction blocker) has
been shown to block the transport of SR101 between astrocytes
[12].
In vivo staining of cortical astrocytes can also be obtained after a
topical application of SR101 on the cortex [12]. Here, we showed
that this local staining method of the astrocytic network was
limited by the diffusion of the dye in brain parenchyma. When a
SR101 intracerebral injection was performed, the dye specificity
for astrocytes was improved, but the staining was spatially limited
to the injection site and time-limited due to the dilution of dye in
the astrocytic network. In contrast, using the iv injection method,
our data suggest that all astrocytes in the entire brain were stained
via the cerebral blood circulation for more than 5 hours. The
sulforhodamine dye was cleared from the blood after 1 or 2 hours
depending on the quantity of the dye injected, age of animals and
the species. The iv staining includes not only protoplasmic
astrocytes, but also marginal and perivascular ones, as well as
Bergmann glia cells in the cerebellum and radial astrocytes in the
hippocampus [40,41]. Therefore, the astrocyte staining clearly
appears ubiquitous and homogeneous which makes this method
more suitable for whole brain astrocytes observations using e.g. in
vivo endoscopy (not published data).
In this study, we verified whether the staining of the astrocytic
population was compatible with physiological experiments. First,
we showed that EEG recordings after iv injection of either SRB or
SR101 did not reveal any epileptiform activity for up to 3 days
post-injection. This lack of adverse effects was confirmed with the
astrocytes calcium activity after iv sulforhodamine staining. This
staining did not alter the astrocyte calcium oscillations in vivo
according to the literature [11,35].
The new iv method may enable longitudinal studies of the
astrocytic network after repeated iv injections in the same animal
Figure 7. 3D morphological analysis of the astrocytic network after iv injection of SRB. A) A multistacks mosaic acquired in the
somatosensory area of a coronal acute brain slice (P17 rat). The region of interest (ROI; white rectangle) shows colored astrocytes detected using
ImageJ plugins. Each color corresponds to single astrocytes cell body. Scale bar=150 mm. B) Frequency histogram showing of astrocyte densities as a
function of cortical depth calculated from the ROI described above. Depth was divided in 15 bins with 100 mm increments. C) Frequency histogram of
normalized astrocytes radial densities in the cortical layer 1 and E) in layers 2/3. D) TPLSM images showing astrocytes in the cortical layer 1 and F)i n
layers 2/3. Scale bar=25 mm.
doi:10.1371/journal.pone.0035169.g007
Figure 8. Rearrangement of the astroglial network in a mouse
model of mesiotemporal lobe epilepsy. A–B) Bright field
microscopy imaging (Nikon Multizoom AZ100, France) of acute
hippocampal slices from adult mice 2 weeks after a unilateral
intrahippocampal kainate injection. A) Contralateral non-injected
hippocampus. B) Ipsilateral hippocampus. Note the absence of CA1/
CA3 areas and the enlargement of the dentate gyrus. C–D) TPLSM
imaging of regions indicated by white squares on (A) and (B) images,
respectively, after iv injection of SR101. Scale bar=50 mm. E) Column
scatters representation showing the distribution of astrocytes cell body
volumes at both sides of the hippocampus. The bar corresponds to the
mean value.
doi:10.1371/journal.pone.0035169.g008
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are more convenient than repeated intracerebral injections that
are invasive and may induce tissue lesion. This may be useful in
cerebral stroke models, where changes in astrocyte morphology
and function after a permanent or a transient occlusion have an
impact on neuronal functions over time [43]. Another application
may be the understanding of the relationships between neuronal
activation and local cerebral vascular dynamics via the astrocytic
network [44]. Transfected calcium indicators [45], transgenic
mice with fluorescent neurons [46] and additional iv injections of
FITC-dextran and sulforhodamine for the staining of respectively
the cerebral vasculature and astrocytes might be used to avoid
intracerebral injections. The iv method leads to a more
exhaustive labeling of astrocytes in comparison to transgenic
animals. Indeed, SRB iv injection in GFAP-GFP transgenic mice
revealed that only 40% of the SRB stained astrocytes were GFP
+.
These data confirm the fact that only a subpopulation of
astrocytes can be detected in transgenic mice, likely due to
variation in the promoter expression and/or GFP protein levels
in the cells [47]. At the opposite, 10% of GFAP-GFP cells were
not stained by SRB in transgenic mice. These cells could be
attributed to astrocytic precursors such as NG2 cells that do not
possess functional endfeet [48,49] for SRB uptake from the
cerebral vasculature.
The current method can also be used for experiments on acute
brain slices of mice and rats. The commonly used method consists
in the incubation of brain slices with sulforhodamine [24], leading
to a neuronal staining at the surface of the slice. This uptake of the
sulforhodamine by neurons in vitro might be due to the damage or
swelling of neurons during the slice preparation [50]. On the
contrary, when acute brain slices were prepared after our iv
staining method, astrocytes were observed in the whole slice from
any brain regions without any neuronal staining.
Comparing to others, our method results in a homogeneous
astrocytes staining in the entire brain and its high contrast allowed
us to perform a 3D quantitative analysis of astrocytic network. In
this study, the astrocytic network in a mouse model of epilepsy was
quantitatively analyzed, confirmed and extended previous immu-
nohistochemical observations in the same model [22].
In conclusion, astrocytes staining using the iv injection method
is specific, ubiquitous, exhaustive and appears a powerful tool that
can be combined with other methods to study the astrocytes
functions in different rodent species. In particular, our method
opens new perspectives for calcium imaging and patch-clamp
techniques on astrocytes in vivo or in vitro. It will also help in
pathophysiological studies of astrocyte dysfunction in neurological
disorders such as stroke, epilepsy, Alzheimer and Parkinson’s
diseases [51].
Supporting Information
Figure S1 EEG recordings of freely moving rats after iv
injection of SRB or SR101. EEG in both somatosensory and
motor cortex and in hippocampus (rat P25) after an intravenous
injection of SRB did not reveal any epileptic seizures even after
recording sessions of 3 h during 3 days.
(TIF)
Figure S2 Multistacks mosaics of large brain areas
showing different pattern of sulforhodamines labeling.
A) Large view of the cerebellum (322462212 mm) showing
astrocytes and blood vessels stained after iv injection of both
SRB (red) and FITC-dextran (green). B) Astrocytes staining in the
whole hippocampus (298261882 mm) after iv injection of SR101.
(TIF)
Figure S3 Multistacks mosaic of astrocytes staining in
all cortical layers of the S1BF cortex after iv injection of
SR101 (222962194 mm).
(TIF)
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